Literature DB >> 3277572

Group B streptococcal sepsis in adults and infants. Contrasts and comparisons.

S M Opal1, A Cross, M Palmer, R Almazan.   

Abstract

Group B streptococcal infection may result in significant morbidity and mortality in both infants and adults. The experience with group B streptococcal disease was analyzed at one medical center over a ten-year period from 1975 to 1984. Streptococcus agalactiae bacteremia was observed in 29 adults and 26 infants, with an attack rate of 0.2 cases per 1000 adult admissions and 3.2 cases per 1000 live births, respectively. The majority of adult infections apparently occurred as a result of nosocomial acquisition and was associated with a high mortality rate of 38%. Risk factors for group B streptococcal sepsis in adults include diabetes mellitus, malignancy, and hepatic failure. The majority (73%) of neonatal cases occurred within seven days of birth and occurred in a setting of maternal fever, prolonged rupture of membranes, or prematurity. The mortality rate in infants was remarkably low at only 15%. Fatalities occurred in both adults and infants, despite appropriate antimicrobial therapy. Infection control strategies against group B streptococcus must address potential nosocomial dissemination in adults as well as vertical transmission in infants.

Entities:  

Mesh:

Year:  1988        PMID: 3277572

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

1.  Soluble antigens from group B streptococci induce cytokine production in human blood cultures.

Authors:  C von Hunolstein; A Totolian; G Alfarone; G Mancuso; V Cusumano; G Teti; G Orefici
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 2.  Group B streptococcal toxic shock syndrome in an asplenic patient: case report and literature review.

Authors:  K D Sims; T D Barton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

3.  Typing of group B streptococci: comparison of pulsed-field gel electrophoresis and conventional electrophoresis.

Authors:  M E Gordillo; K V Singh; C J Baker; B E Murray
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

4.  High-level chromosomal gentamicin resistance in Streptococcus agalactiae (group B).

Authors:  A Buu-Hoï; C Le Bouguenec; T Horaud
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).

Authors:  C von Hunolstein; S D'Ascenzi; B Wagner; J Jelínková; G Alfarone; S Recchia; M Wagner; G Orefici
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

6.  Properties and type antigen patterns of group B streptococcal isolates from pigs and nutrias.

Authors:  I W Wibawan; C Lämmler; J Smola
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

Review 7.  Group B streptococcal infection in older patients. Spectrum of disease and management strategies.

Authors:  M M Farley
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

Review 8.  Group B streptococcal meningitis in a 5-year-old boy.

Authors:  Sanjeev Managoli; Pushpa Chaturvedi; Krishna Y Vilhekar
Journal:  Indian J Pediatr       Date:  2003-06       Impact factor: 1.967

Review 9.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

Review 10.  Epidemiology of group B streptococcal disease in the United States: shifting paradigms.

Authors:  A Schuchat
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.